Search for Clinical Trial Results
Anemia, Hemolytic - 1542 Studies Found
Status | Study |
Completed |
Study Name: Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel Condition:
Date: 2009-09-03 Interventions: Other: Medical records summary Summary of Medical files and laboratory results. |
Completed |
Study Name: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias Condition:
|
Completed |
Study Name: A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis Condition: Renal Tubular Acidosis, Distal, With Hemolytic Anemia Date: 2015-07-02 Interventions: Other: No intervention No intervention was administered in this study. |
Completed |
Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease Condition:
Date: 2016-02-16 Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab |
Completed |
Study Name: Immunoglobulin Dosage and Administration Form in CIDP and MMN Condition:
Interventions: Drug: Immunoglobulins SCIG dosage is individualized for each patient according to previous IVIG dosage |
Completed |
Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condition: Chronic Lymphocytic Leukemia Date: 2006-03-29 Interventions:
|
Recruiting |
Study Name: Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias Condition:
Date: 2003-05-29 Interventions:
|
Active, not recruiting |
Study Name: Pyruvate Kinase Deficiency Natural History Study Condition:
|
Completed |
Study Name: Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients Condition:
|
Recruiting |
Study Name: SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain Condition:
|